Morphological, biochemical, histological, and ultrastructural protective effects of misoprostol on cisplatin induced-hepatotoxicity in adult male rats

Saudi Medical Journal

Volumn 34, Issue 12, 2013, Pages 1237-1247

  Nasr, Ashraf Y ^a,b  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CISPLATIN; COLLAGEN; GLYCOGEN; MISOPROSTOL; MISOTAC; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ELECTRON MICROSCOPY; KUPFFER CELL; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; RAT; TISSUE SECTION; ANIMAL; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; LIVER; METABOLISM; PATHOLOGY; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG-INDUCED LIVER INJURY; LIVER; MALE; MISOPROSTOL; RATS, WISTAR;

EID: 84891054650     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gottfried M, Ramlau R, Krzakowski M, Ziolo G, Olechnowicz H, Koubkova L, et al. Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final results. J Thorac Oncol 2008; 3: 152-157.
2. Ajani JA. Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastro-esophageal junction: Evolution of the docetaxel, cisplatin and 5-fluorouracil regimen. Cancer 2008; 113: 945-955.
3. Mansour HH, Hafez HF, Fahmy NM. Silymarin modulates Cisplatin 10 mg kg-1 induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol 2006; 39: 656-661.
4. El-Sayyad HI, Ismail MF, Shalaby FM, Abou-El-Magd RF, Gaur RL. Histopathological effects of cisplatin, doxorubicin and 5-flurouracil (5-FU) on the liver of male albino rats. Int J Biol Sci 2006; 5: 466-473.
5. Abdelmeguid NE, Chmaisse HN, Abou Zeinab NS. Silymarin Ameliorates Cisplatin-Induced Hepatotoxicity in Rats: Histopathological and Ultrastructural Studies. Pak J B Sci 2010; 13: 463-479.
6. Asci H, Ozer MK, Calapoglu M, Savran M, Oncu M, Yesilot S, Candan IA, Klac E, and Cicek E. Effect of misoprostol on methotrexate-induced hepatic and renal damages. J Bio Life Sci 2011; 2: 32-37.
7. Ozer MK, Halil A, Moncu MC, Savran M, Calapoglu M, Yesilot S, Candan IA et al. Effects of misoprostol on cisplatininduced renal damage in rats. Food Chem Toxicol 2011; 49: 1556-1559.
8. Arhoghro EM, Kpomah DE, Uwakwe AA. Curative Potential of Aqueous Extract of Lemon Grass (Cymbopogon Citratus) on Cisplatin Induced Hepatotoxicity in Albino Wistar Rats. J Phys Pharm Adv 2012; 2: 282-294.
9. Brunton LL, Lazo JS, Parker KI. Goodman and Gilman's the pharmacological basis of therapeutics. New York: Mc Graw Hill Companies; 2006.
10. Salam OME, Sleem AA, Omara EA, Hassan NS. Hepatoprotective effects of misoprostol and silymarin on carbon tetrachloride-induced hepatic damage in rats. Fundam Clin Pharmacol 2009; 23: 179-188.
11. Reitman S, Frankel S. In vitro determination of transaminases activity in serum. Am J Clin Pathol 1957; 28: 56-62.
12. Bancroft JD, Gamble M. Theory and practice of histological techniques. 5th ed. Philadelphia (PA): Churchill Livingstone; 2002: 125-138, 172-175, 184-193, 593-620.
13. Chirino YI, Hernandez-Pando J, Pedraza-Chaveri J. Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol 2004; 4: 20-29.
14. Mora LO, Antunes HD, Fransescato HD, Bianchi M. The effect of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 2003; 47: 517-522.
15. Lee CK, Park SS, Lim JH, Chung YW. Effects of the licorice extract against tumor growth and cisplatin-induced toxicity in a mouse xenograft model of colon cancer. Biol Pharm Bull 2007; 30: 2191-2195.
16. Ajith TA, Usha S, Nivitha V. Ascorbic acid and alpha-tocopherol protect anticancer drug cisplatin induced nephrotoxicity in mice: a Comparative study. Int J Clin Chem 2007; 375: 82-86.
17. Park HR, Ju EJ, Jo SK, Jung U, Kim SH, Yee ST. Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice. BMC Cancer 2009; 9: 85.
18. Kart A, Yilmaz C, Musa K, Hasan O. Caffeic acid phenethyl ester (CAPE) ameliorates cisplatin-induced hepatotoxicity in rabbit. Experimental and Toxicological Pathology 2010; 62: 45-52.
19. Yüce A, Atessahin A, Çeribasi A, Aksakal M. Ellagic Acid Prevents Cisplatin-Induced Oxidative Stress in Liver and Heart Tissue of Rats. Basic Clin Pharmacol Toxicol 2007; 101: 345-349.
20. Hanigan H, Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 2003; 1: 47-61.
21. Ranchal I, Gonzalez R, Lopez-Sanchez LM et al. The differential effect of PGE1 on D-galactosamine-induced nitosative stress and cell death in primary culture of human hepatocytes. Prostaglandins Other Lipid Mediat 2006; 79: 245-259.
22. Ros S, Juanola XC, Riera J, Del Blanco J, Rebasa P, Valverde j, Roig-Escofet O. Light and Electron microscopic analysis of liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Scand J Rheumatol 2002; 531: 330-336.
23. Kumar V, Abbas AK, Aster CJ. Basic Pathology. 9th ed. Philadelphia (PA): WB Saunders Company; 2013.
24. Pratibha RK, Dayanand AB. Cisplatin induced histological and ultrastructural alterations in liver tissue rat. J Cytol Histol 2011; 2: 128-132.